Association of cytokine responses with disease severity in infants with respiratory syncytial virus infection

Acta Paediatrica, International Journal of Paediatrics

Volumn 91, Issue 9, 2002, Pages 914-922

  Chen, Z M ^a   Mao, J H ^a   Du, L Z ^a   Tang, Y M ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Flow cytometry; Interferon ; Interleukin 12; Interleukin 4; Respiratory syncytial virus

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

AIRWAY OBSTRUCTION; ANTIGEN EXPRESSION; ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; INFANT; LYMPHOCYTE; MALE; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TH2 CELL; VIRUS INFECTION; VIRUS REPLICATION;

ANALYSIS OF VARIANCE; ANTIGENS, CD4; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; CYTOKINES; FEMALE; FLOW CYTOMETRY; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; MALE; PROBABILITY; REFERENCE VALUES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0036396333     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/080352502760272588     Document Type: Article

References (29)

1. Hall CB. Respiratory syncytial virus: a continuing culprit and conundrum. J Pediatr 1999; 135: 2-7
2. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161: 1501-7
3. Kneyber MCJ, Steyerberg EW, de Groot R, Moll HA. Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review. Acta Pediatr 2000; 89: 654-60
4. Waris ME, Tsou C, Erdman DD, Zaki SR, Anderson LJ. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J Virol 1996; 70: 2852-60
5. Bembridge GP, Garcia-Beato R, Lopez JA, Melero JA, Taylor G. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein. J Immunol 1998; 161: 2473-80
6. Waris ME, Tsou C, Erdman DD, Day DB. Anderson LJ. Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV. J Virol 1997; 71: 6935-9
7. Hussell T, Georgiou A, Sparer TE, Matthews S, Pala P, Openshaw PJ. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection. J Immunol 1998; 161: 6215-22
8. + T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur J Immunol 1997: 27: 3341-9
9. Ramshaw IA, Ramsay AJ, Karupiah G, Rolph MS, Mahalingam S, Ruby JC. Cytokines and immunity to viral infections. Immunol Rev 1997; 159: 119-35
10. Openshaw PJM, Hewitt C. Protective and harmful effects of viral infections in childhood on wheezing disorders and asthma. Am J Respir Crit Care Med 2000; 162: S40-3
11. Van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC II. Welliver RC. Increased production of IFN-γ and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 1999; 103: 630-6
12. Van Schaik SM, Obot N, Enhorning G, Hintz K, Gross K, Hancock GE, et al. Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J Meal Virol 2000; 62: 257-66
13. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JTM, et al. Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur Respir J 1999; 14: 144-9
14. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JTM, et al. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. Am J Respir Crit Care Med 2000; 161: 1518-23
15. Roman M, Calhoun WJ, Hinton KL, Avendano LF, Simon V, Escobar AM, et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Car Med 1997; 156: 190-5
16. Sewell WA, North ME, Webster AD, Farrant J. Determination of intracellular cytokines by flow-cytometry following whole-blood culture. J Immunol Methods 1997; 209: 67-74
17. Rudwaleit M, Yin Z, Siegert S, Grolms M, Radbruch A, Braun J, et al. Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor α, increase of interleukin 10, and predicted by the initial concentration of interleukin 4. Ann Rheum Dis 2000; 59: 311-4
18. Bendelja K, Gagro A, Bace A, Lokar-Kolbas R, Krsulovic-Hresic V, Drazenovic V, et al. Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin Exp Immunol 2000; 121: 332-8
19. Brandenburg AH, Kleinjan A, van Het Land B, Moll HA, Timmerman HH, de Swart RL, et al. Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity. J Med Virol 2000; 62: 267-77
20. McDyer JF, Wu CY, Seder RA. The regulation of IL-12: its role in infectious, autoimmune, and allergic diseases. J Allergy Clin Immunol 1998; 102: 11-5
21. Karp CL, Wysocka M, Wahl LM, Ahearn SM, Cuomo PJ, Sherry B. Mechanisms of suppression of cell-mediated immunity by measles virus. Science 1996; 273: 228-31
22. Bont L, Kavelaars A, Heijnen CJ, van Vught AJ, Kimpen JLL. Monocyte interleukin-12 production is inversely related to duration of respiratory failure in respiratory syncytial virus bronchiolitis. J Infect Dis 2000; 181: 1772-5
23. + cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children. J Infect Dis 2001; 183: 687-96
24. Ehlenfield DR, Cameron K, Welliver RC. Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics 2000; 105: 79-83
25. Takafuji S, Ohtoshi T, Takizawa H, Tadokoro K, Ito K. Eosinophil degranulation in the presence of bronchial epithelial cells. J Immunol 1996; 156: 3980-5
26. Garofalo RP, Patti J, Hintz KA, Hill V, Ogra PL, Welliver RC. Macrophage inflammatory protein-1alpha (not t helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis 2001; 184: 393-9
27. Aberle JH, Aberle SW, Dworzak MN, Mandl CW, Rebhandl W, Vollnhofer G, et al. Reduced interferon-γ expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med, 1999; 160: 1263-8
28. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JTM, et al. Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis 2001; 184: 355-8
29. Renzi PM, Turgeon JP, Yang JP, Drblik SP, Marcotte JE, Pedneault L, et al. Cellular immunity is activated and a TH-2 response is associated with early wheezing in infants after bronchiolitis. J Pediatr 1997; 130: 584-93